- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07256496
Enhanced Dialectical Behavior Therapy for Adolescents
November 20, 2025 updated by: Megan Plakos Szabo, Compass Behavioral Health
Enhanced Dialectical Behavior Therapy for Adolescents: Impacts of Individualized Skills Coaching on Constructs of Suicidality
Suicide is a leading cause of death and significant concerns for adolescents and young adults.
Dialectical Behavior Therapy for Adolescents (DBT-A) is an evidence-based intervention that effectively reduces life-threatening behaviors.
Limited research examines the impact of adding individualized skills coaching sessions (ISCS) to the DBT-A model, a novel intervention referred to in this paper as "Enhanced DBT-A".
This study evaluates the effectiveness of Enhanced DBT-A in reducing suicidality over 1 year of treatment in an outpatient and intensive outpatient setting.
Study Overview
Study Type
Interventional
Enrollment (Actual)
47
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Tustin, California, United States, 92780
- Compass Behavioral Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- appropriateness for Stage 1 DBT, completion of all assessments within the designated timeframe, a non-zero score on the Columbia-Suicide Severity Rating Scale (C-SSRS) at intake, and participation in at least one ISCS between intake and 1 year from the first individual therapy session.
Exclusion Criteria:
- presenting with active psychosis, a primary diagnosis of substance use, who did not consent to data collection, or who had a zero score on the C-SSRS at intake
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Enhanced DBT-A Group
Participants engaged in Enhanced DBT-A services, including individual therapy, group skills training, phone coaching, and ISCS.
Participants completed assessment batteries at intake, 6 months, and 1 year, and the outcome measures assessed participants' severity and intensity of suicidal ideation (SI), reasons for living, and depressive symptoms.
|
Participants engaged in Enhanced DBT-A services, including individual therapy, group skills training, phone coaching, and ISCS.
Participants completed assessment batteries at intake, 6 months, and 1 year, and the outcome measures assessed participants' severity and intensity of suicidal ideation (SI), reasons for living, and depressive symptoms.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reasons for Living Inventory for Adolescents (RFL-A)
Time Frame: 1 year
|
The Reasons for Living Inventory for Adolescents (RFL-A; Osman et al, 1998) is a 32-item self-report questionnaire that assesses adaptive reasons that may prevent an adolescent from engaging in life-threatening behavior.
|
1 year
|
|
PHQ-9
Time Frame: 1 year
|
The current study administered the PHQ-9 to participants 18 years and older.
The PHQ-9 (Kroenke et al, 2001) is a widely-used and psychometrically-robust self-report measure used to assess the prevalence of depressive symptoms in adults during a two-week period.
|
1 year
|
|
Columbia-Suicide Severity Rating Scale - Self Report Screener - Recent (C-SSRS).
Time Frame: 1 year
|
To capture the severity and intensity of participants' SI and their corresponding suicide risk, we used items from the Columbia-Suicide Severity Rating Scale - Screen Version - Recent (C-SSRS; Posner et al, 2011).
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 17, 2014
Primary Completion (Actual)
August 26, 2022
Study Completion (Actual)
August 26, 2022
Study Registration Dates
First Submitted
November 20, 2025
First Submitted That Met QC Criteria
November 20, 2025
First Posted (Actual)
December 1, 2025
Study Record Updates
Last Update Posted (Actual)
December 1, 2025
Last Update Submitted That Met QC Criteria
November 20, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00078098
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicidality
-
Janssen Scientific Affairs, LLCCompletedSuicidalityUnited States
-
Sinead NugentUnknownAdolescent Suicidality
-
VA Eastern Colorado Health Care SystemUS Department of Veterans Affairs; The Catholic University of AmericaCompleted
-
University of California, Los AngelesActive, not recruiting
-
University of ZurichCompletedSuicide, Attempted | SuicidalitySwitzerland
-
San Diego State UniversityUniformed Services University of the Health Sciences; Palo Alto Veterans Institute...Recruiting
-
Rabin Medical CenterCompleted
-
Children's Hospital Medical Center, CincinnatiActive, not recruitingSuicidality | Depression DisordersUnited States
-
Prof. Yoram YovellUniversity of HaifaUnknown
-
VA Eastern Colorado Health Care SystemUniversity of Colorado, DenverWithdrawn
Clinical Trials on Enhanced DBT-A
-
Oslo University HospitalUniversity of OsloCompletedBorderline Personality Disorder | Self-Harm, DeliberateNorway
-
University of OttawaCompletedBorderline Personality Disorder | Deliberate Self Harm
-
Rutgers, The State University of New JerseyCompletedBorderline Personality Disorder in AdolescenceUnited States
-
Haukeland University HospitalRecruitingSuicidal Ideation | Self-harm | Suicide and Self-harmNorway
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; St. Olavs Hospital; Nordlandssykehuset... and other collaboratorsRecruitingBorderline Personality Disorder | Self HarmNorway
-
University of WashingtonNational Institute of Mental Health (NIMH)CompletedSuicide | Borderline Personality DisorderUnited States
-
Weill Medical College of Cornell UniversityGreen Chimneys Residential Treatment Center, Brewster, NYCompletedChildhood AggressionUnited States
-
University Hospital, MontpellierINSERM 1061, " Neuropsychiatry: epidemiological and clinical research", MontpellierWithdrawnFemale | Borderline Personality DisorderFrance
-
Klaus SchmeckPontificia Universidad Catolica de Chile; Heidelberg UniversityCompletedPersonality Disorders | Borderline Personality DisorderChile, Germany, Switzerland
-
Bogazici UniversityRecruitingEmotion RegulationTurkey (Türkiye)